Eli Lilly
LLY on XNYS, Eli Lilly & Co.
Measures activity, not value. Not investment advice.
Bought, last 12 months
$0
-100% vs the 12 months before
Sold, last 12 months
$3.6B
+243% vs the 12 months before
Net, last 12 months
-$3.6B
bought minus sold
Sharp changes
2
clustered insider buying
What usually follows Companies in the top fifth of insider net purchases (90 days, per $1M of company value, in $100s) beat their sector by a median 0.3 points over the next 6 months, against +2.6 points for the bottom fifth. Clear How we measured it
Who traded
Insiders with counted open-market trades, largest total first. Each name opens every trade of that person, at every company| Insider | Role | Purchases | Sales | Latest trade |
|---|---|---|---|---|
| Lilly Endowment Inc | Former 10% Shareholder | – | 314$12.4B | 6 May 2026 |
| Alfonso G Zulueta | SVP & President, Lilly Int'l | – | 15$15.5M | 9 Jul 2020 |
| Anat Hakim | EVP, GC & Secretary | – | 2$13.0M | 2 Nov 2026 |
| Donald A Zakrowski | SVP, Finance, & CAO | – | 28$12.4M | 10 Aug 2026 |
| Patrik Jonsson | EVP & President, LLY Int'l | – | 4$10.6M | 17 Aug 2026 |
| Myles O'Neill | SVP & Pres., Mfg. Operations | – | 3$9.3M | 4 Mar 2020 |
| Johna Norton | EVP, Global Quality | – | 3$7.9M | 3 Jun 2024 |
| Stephen F Fry | SVP, HR & Diversity | – | 6$7.4M | 17 Aug 2020 |
| Enrique A Conterno | SVP&Pres, LillyDiab & LillyUSA | – | 3$7.2M | 15 Feb 2019 |
| Susan Mahony | SVP & Pres., Lilly Oncology | – | 3$6.4M | 13 Apr 2018 |
| Daniel Skovronsky | EVP, CSO & Pres. LRL & LLY Imm | 3$2.0M | 1$4.3M | 12 Aug 2025 |
| Ilya Yuffa | EVP&Pres, LLY USA&Global Capab | – | 4$5.1M | 10 Jun 2026 |
| Michael J Harrington | Senior VP and General Counsel | – | 2$3.7M | 3 Jun 2019 |
| Jeffrey N Simmons | SVP&Pres. Elanco Animal Health | – | 3$2.6M | 3 May 2018 |
| David A Ricks | President, Chair, and CEO | 2$1.6M | 1$445K | 12 Aug 2025 |
Form 4 open-market trades, by trade date. Incomplete recent periods left out.
See the numbers
| Month of Aug 2026: bought $0, sold $16.0M |
| Month of Jun 2026: bought $0, sold $2.9M |
| Month of May 2026: bought $0, sold $15.8M |
| Month of Jan 2026: bought $0, sold $323.9M |
| Month of Dec 2025: bought $0, sold $7.0M |
| Month of Nov 2025: bought $0, sold $2.2B |
| Month of Oct 2025: bought $0, sold $883.4M |
| Month of Sep 2025: bought $0, sold $99.6M |
| Month of Aug 2025: bought $4.5M, sold $1.5M |
| Month of Jul 2025: bought $0, sold $225.4M |
| Month of May 2025: bought $0, sold $1.7M |
| Month of Mar 2025: bought $0, sold $205.1M |
| Month of Feb 2025: bought $0, sold $583.5M |
| Month of Nov 2024: bought $0, sold $723K |
| Month of Sep 2024: bought $0, sold $23.3M |
| Month of Aug 2024: bought $0, sold $27.6M |
| Month of Jul 2024: bought $0, sold $394.5M |
| Month of Jun 2024: bought $0, sold $916.3M |
| Month of May 2024: bought $0, sold $383.9M |
| Month of Mar 2024: bought $0, sold $565K |
| Month of Feb 2024: bought $0, sold $380.9M |
| Month of Jan 2024: bought $0, sold $226.8M |
| Month of Nov 2023: bought $0, sold $383K |
| Month of Oct 2023: bought $0, sold $130.2M |
| Month of Sep 2023: bought $0, sold $146.5M |
| Month of Aug 2023: bought $0, sold $401.8M |
| Month of Jul 2023: bought $0, sold $77.0M |
| Month of Jun 2023: bought $0, sold $132.8M |
| Month of May 2023: bought $0, sold $278.2M |
| Month of Apr 2023: bought $0, sold $216.9M |
| Month of Mar 2023: bought $0, sold $67.7M |
| Month of Feb 2023: bought $0, sold $1.7M |
| Month of Dec 2022: bought $0, sold $78.1M |
| Month of Nov 2022: bought $0, sold $74.3M |
| Month of Oct 2022: bought $0, sold $138.1M |
| Month of Sep 2022: bought $0, sold $34.4M |
| Month of Aug 2022: bought $200K, sold $200K |
| Month of Jul 2022: bought $0, sold $94.6M |
| Month of Jun 2022: bought $0, sold $212.3M |
| Month of May 2022: bought $0, sold $229.4M |
| Month of Apr 2022: bought $0, sold $174.1M |
| Month of Mar 2022: bought $50K, sold $360.5M |
| Month of Feb 2022: bought $0, sold $885K |
| Month of Jan 2022: bought $0, sold $1.0M |
| Month of Dec 2021: bought $0, sold $106.5M |
| Month of Nov 2021: bought $0, sold $52.4M |
| Month of Oct 2021: bought $0, sold $50.6M |
| Month of Aug 2021: bought $0, sold $134.3M |
| Month of Jul 2021: bought $0, sold $149.8M |
| Month of Jun 2021: bought $0, sold $160.3M |
| Month of May 2021: bought $250K, sold $40.1M |
| Month of Apr 2021: bought $0, sold $544K |
| Month of Mar 2021: bought $0, sold $38.9M |
| Month of Jan 2021: bought $0, sold $120.9M |
| Month of Sep 2020: bought $0, sold $755K |
| Month of Aug 2020: bought $0, sold $1.1M |
| Month of Jul 2020: bought $0, sold $100.7M |
| Month of Jun 2020: bought $0, sold $80.6M |
| Month of Apr 2020: bought $0, sold $168.0M |
| Month of Mar 2020: bought $0, sold $35.8M |
What the numbers say
- Bought $0 (-100% on the year before) vs sold $3.6B in the 12 months to Aug 2026.
- Insider net buying over 12 months: -$814.5M, number 653 of 658 Health Care companies with data (median -$372K).
- 2 sharp changes in all loaded history (clustered insider buying).
- Open-market trades in the last 12 months by who traded: the largest is ten-percent owners sold, $812.0M (95%).
- Latest record: Hakim Anat (EVP, GC & Secretary) sold 5,000 shares of LLY ($7.0M), public on 3 Nov 2026.
See the numbers
| Ten-percent owners sold | $812.0M (95%) |
| Officers sold | $25.8M (3.0%) |
| Others sold | $15.8M (1.8%) |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
2 in all loaded history, strongest first
Eli Lilly had 5 insiders buy $2.9M of its shares on the open market within 30 days (5 filings).
Who bought: Jackson Jamere, Skovronsky Daniel, Fyrwald J Erik, Sulzberger Gabrielle and 1 more.
See the evidence (5 source records)
- Independent buyers
- 5
- Purchase filings (Form 4, code P)
- 5
- Total bought
- $2.9M
- Window
- 14 Jul 2025 to 13 Aug 2025
- JACKSON JAMERE (director) bought 200 shares of LLY ($127,912)dated 8 Aug 2025, public 9 Aug 2025
- Skovronsky Daniel (EVP, CSO & Pres. LRL & LLY Imm) bought 1,000 shares of LLY ($634,410)dated 12 Aug 2025, public 13 Aug 2025
- Fyrwald J Erik (director) bought 1,565 shares of LLY ($1.0M)dated 12 Aug 2025, public 13 Aug 2025
- Sulzberger Gabrielle (director) bought 117 shares of LLY ($75,018)dated 12 Aug 2025, public 13 Aug 2025
- Ricks David A (President, Chair, and CEO) bought 1,632 shares of LLY ($1.1M)dated 12 Aug 2025, public 13 Aug 2025
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Eli Lilly had 5 insiders buy $1.5M of its shares on the open market within 30 days (5 filings).
Who bought: Tai Jackson P, Ricks David A, White Anne E., Skovronsky Daniel and 1 more.
See the evidence (5 source records)
- Independent buyers
- 5
- Purchase filings (Form 4, code P)
- 5
- Total bought
- $1.5M
- Window
- 29 Sep 2019 to 29 Oct 2019
- TAI JACKSON P (director) bought 1,861 shares of LLY ($200,039)dated 25 Oct 2019, public 26 Oct 2019
- Ricks David A (President & CEO) bought 4,615 shares of LLY ($500,174)dated 25 Oct 2019, public 26 Oct 2019
- White Anne E. (SVP & Pres-Lilly Oncology) bought 1,000 shares of LLY ($108,840)dated 28 Oct 2019, public 29 Oct 2019
- Skovronsky Daniel (SVP, CSO, and Pres. LRL) bought 5,000 shares of LLY ($543,050)dated 28 Oct 2019, public 29 Oct 2019
- Smiley Joshua L (SVP and CFO) bought 929 shares of LLY ($99,951)dated 28 Oct 2019, public 29 Oct 2019
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
The records
Newest first, by the day each became public